The UK National Health Service lists twelve symptoms of COVID-19 in adults, from odor loss to high fever. Even people who are mild-tempered and have symptoms from home may notice chronic health effects, such as fatigue or shortness of breath. If symptoms persist for more than a few months, people can be diagnosed with a disease commonly known as long-term COVID.
To estimate how the disease affects the entire population, scientists compiled data on individual experiences. This includes the number of people infected with the virus, the number of symptoms, the duration of the disease, how many need to be treated in hospital or died, and the age of the patients, among other things. Then use them to determine how many years you have lost as a result of the disease and how many years you have lived with symptoms of disability.
Researchers can use the average life expectancy in the world to determine how many years it has lost due to premature death. Loss due to disability is difficult to calculate, however. To quantify those, researchers used data on the number of people affected by a particular illness, the length of time they had and the number of illnesses known as weight gain. IHME’s Global Burden of Disease Group maintains a standard list of disability weight.
Currently, there is no standard weight loss for COVID-19. Instead, researchers use the weight of disability associated with other infectious diseases and similar health conditions.Addition of years of life lost as a result of illness, disability or premature death provides a measure of unit load known as disability-adjusted life.It is a key research tool for disease burden.
Data entering DALY comes from a variety of sources. Most are usually collected by national health authorities. In COVID-19, some data was collected through targeted monitoring efforts such as REACT study (Real-time Assessment of Community Transmission), a large sample activity that began in 2020 and documented how SARS-CoV-2 is progressing in England and what symptoms people experience.
Data from the REACT study suggest that the health effects of COVID-19 may be longer. An earlier edition posted on medRxiv server last July suggested that 19% of English people had COVID-19, and that about one-third of those – over two million adults – had symptoms of one or more symptoms for at least 12 weeks. “That’s 6% of the population,” said Paul Elliot, an epidemiologist at Imperial College London, who led the REACT study and co-authored the study.
Max Taquet, a health researcher and engineer at the University of Oxford, UK, who uses data from medical records to understand the neurological and psychological effects of COVID-19, says that estimating COVID’s long-term health effects is difficult and the numbers alarming. “Most of us are amazed at the level of the problem,” he said, “but we do see the post-infection syndrome and other viral infections.” With COVID-19, scientists monitor the results in real time. “It’s good that we’re finally paying attention.”
There is no guarantee that these data sources will always exist, however. The UK government announced in March that it would suspend funding for certain REACT research branches and another monitoring effort.
Premature health effects lost to COVID-19 are intrusive. “Overall, the impact of COVID-19 has been extremely high worldwide,” said Gianfranco Politano, a biologist at the Polytechnic University of Turin in Italy, who participated in blood tests. a study of 16 European countries. Each country analysis also reveals significant differences in the health burden of COVID-19. A study from Malta shows that between March 2020 and March 2021, COVID-19 became the fourth leading cause of disability, accounted for after heart disease, lower back pain and diabetes5. In India, it is very low on the list: using the 2019 data as a guide, it would account for about 3% of the total health burden.
A network of epidemiologists and public health researchers from 53 countries around the world quickly recognized the need to document the public health burden of a recent epidemic, and began to form a consensus agreement, including a specific model of COVID-19 progression from infection to recovery or recovery. to death. “Since then, many countries have adopted the practice. We never thought it would happen so quickly, ”said Monteiro Pires, who leads the network’s communications team. Network researchers have now completed the load estimates for Malta, Denmark, the Netherlands, Scotland, Ireland and Germany, and more is expected to emerge in the coming months.
There are still no global health statistics from COVID-19, but IHME has been releasing catalogs for some diseases since the 1990’s. In early 2020, when it became clear that the epidemic was raging, the institute had a machine to help us understand the broader health outcomes of SARS-CoV-2 and began working to add COVID-19 to the catalog. About 100 employees were diverted from the effort. Their data is currently under consideration. contrast to many other calculations, the data include estimates of the burden of long COVID. Vos has presented these unpublished data to US authorities to help them get a handle on how the lingering symptoms could affect people’s ability to work. The findings suggest that in 2020 and 2021, an estimated 4.6 million people in the United States had symptoms that persisted for at least three months. The group’s definition of long COVID revolves around three clusters of symptoms, centring on fatigue, cognitive problems and ongoing respiratory issues. More than 85% of these cases came as a result of a bout of COVID-19 that did not require hospital treatment.
READ ALSO : Economy Focus: Economic concern at the European Union research program
